Skip to main content
Article thumbnail
Location of Repository

Circulating Vitamin D and Risk of Epithelial Ovarian Cancer

By Alan A. Arslan, Tess V. Clendenen, Karen L. Koenig, Johan Hultdin, Kerstin Enquist, Åsa Ågren, Annekatrin Lukanova, Hubert Sjodin, Anne Zeleniuch-Jacquotte, Roy E. Shore, Göran Hallmans, Paolo Toniolo and Eva Lundin

Abstract

We conducted a nested case-control study within two prospective cohorts, the New York University Women's Health Study and the Northern Sweden Health and Disease Study, to examine the association between prediagnostic circulating levels of 25-hydroxy vitamin D (25(OH)D) and the risk of subsequent invasive epithelial ovarian cancer (EOC). The 25(OH)D levels were measured in serum or plasma from 170 incident cases of EOC and 373 matched controls. Overall, circulating 25(OH)D levels were not associated with the risk of EOC in combined cohort analysis: adjusted OR for the top tertile versus the reference tertile, 1.09 (95% CI, 0.59–2.01). In addition, there was no evidence of an interaction effect between VDR SNP genotype or haplotype and circulating 25(OH)D levels in relation to ovarian cancer risk, although more complex gene-environment interactions may exist

Topics: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Publisher: Hindawi Publishing Corporation
Year: 2009
DOI identifier: 10.1155/2009
OAI identifier: oai:doaj.org/article:03e2bce08c49477f856f312479749293
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/1687-8469 (external link)
  • https://doaj.org/toc/1687-8450 (external link)
  • http://dx.doi.org/10.1155/2009... (external link)
  • https://doaj.org/article/03e2b... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.